Abstract:Abstract Background: Congenital heart disease (CHD) is one of the commonly seen malformations, with incidence varying from 7 to 8/1000 live birth. Causes are multifactorial. Routine examination of neonates may miss more than 50% of cases. Pulse oximetry is a simple, noninvasive, bedside test which estimates the percentage of oxygen bound to hemoglobin (oxygen saturation [SpO 2 ]). Detection of critical CHD (CCHD) has been possible with SpO 2 screening. Many countries included SpO 2 as part of newborn screening due to this. As a primary approach, both pre- and post-ductal extremity SpO 2 is measured after 24 h of life. Echocardiography (ECHO) will be done on neonates with SpO 2 readings <95%. Neonates born in high-altitude regions, studies have suggest to use adjusted threshold values. In India, there are limited studies. Aims: The aim of this study was to determine the usefulness of pulse oximetry as a screening tool for early detection of CHD in otherwise asymptomatic newborns. To determine, the accuracy of SpO 2 for detecting clinically unrecognized CCHD in newborns. Materials and Methods: This is a prospective observational study done in the department of pediatrics in a tertiary hospital. The study was conducted over 12 months. During the study period, all neonates born who fulfilled the inclusion criteria were included in the study. After 24 h of life, neonates were examined clinically and the pre- and post-ductal SpO 2 was measured. Neonates with SpO 2 <90% in room air were excluded from the study. If the SpO 2 was between 90% and 94%, clinical examination was repeated, if suspicious of CHD, they were referred for ECHO. If there was no suspicion of CHD, SpO 2 was repeated after 6 h and ECHO was done if SpO 2 ≤95. The difference of SpO 2 >3% between the right upper limb and right lower limb was considered positive. Positive neonates were evaluated with two-dimensional echocardiograph. Inclusion criteria - All hemodynamically stable neonates were born during the study period. Exclusion criteria (1) Antenatally diagnosed cardiac anomalies, (2) Outborn neonates, (3) Parents/guardians are not willing to participate in the study and/or further investigation, (4) Sick neonates and those with SpO 2 <90% at birth. Results: 1117 (83.7%) were eligible for the study out of 1333 neonates born. 669 (59.9%) were born by cesarean section and 448 (40.1%) by vaginal delivery. 996 (89.2%) were born at term (≥37 weeks of gestation) and 121 (10.8%) were preterm (<37 weeks of gestation). The male-to-female ratio was 1.03:1. The mean birth weight of the neonates was 2.91 ± 0.46 kg (mean ± standard deviation). The mean SPO 2 in the right upper limb was 96.62 ± 1.73, in the right lower limb was 96.87 ± 1.76, in the left upper limb was 96.59 ± 1.90, and in the left lower limb was 97.06 ± 1.74. The average SPO 2 difference between the right upper limb and right lower limb was 1.04 ± 1.07. Based on SpO 2, 858 (76.8%) cases were not suspected of having CHD and 259 (23.3%) were suspected of having CHD and were evaluated with ECHO. Six (0.5%) neonates had CHD in whom echo was done. In our study, for detecting CCHD, SPO 2 cutoff value of ≤90% showed 90% sensitivity, 99.94% specificity, 75% positive predictive value, and 99.98% negative predictive value. Conclusions: This study emphasizes noninvasive SPO 2 as reliable and feasible, with good negative predictive value screening for CHD in neonates.

Pulse Oximetry and Auscultation for Congenital Heart Disease Detection

Pulse Oximetry Screening for Detecting Critical Congenital Heart Disease in Neonates

Screening of Newborn by Pulse Oximetry at Birth for the Critical Congenital Heart Disease

Early Pulse Oximetry Screening for Congenital Heart Disease in Asymptomatic NewbornInfants

Role of Pulse Oximetry as a Screening Tool for the Detection of Congenital Heart Disease in Newborn Babies

Neonatal Pulse Oxymetry Screening for Detection of Congenital Heart Disease in Asymptomatic Newborns: A Cross-sectional Study from a Tertiary Care Hospital

Diagnostic value of pulse oximetry combined with cardiac auscultation in screening congenital heart disease in neonates

Neonatal Pulse Oximetry Screening for Congenital Heart Disease

Pulse Oximetry Screening of Newborn for Critical Congenital Heart Disease in Developing Countries

Critical congenital heart disease screening by pulse oximetry in a neonatal intensive care unit

Critical Congenital Heart Disease Detection in the Screening Era: Do Not Neglect the Examination!

Pulse Oximetry Could Significantly Enhance the Early Detection of Critical Congenital Heart Disease in Neonatal Intensive Care Units

Pulse Oximetry with Clinical Assessment to Screen for Congenital Heart Disease in Neonates in China: a Prospective Study

Beyond Critical Congenital Heart Disease: Newborn Screening Using Pulse Oximetry for Neonatal Sepsis and Respiratory Diseases in a Middle-Income Country

Critical congenital heart disease screening with a pulse oximetry in neonates

Pulse oximetry screening for critical congenital heart disease in the neonatal intensive care unit

Pulse Oximetry is a Feasible Method for Detecting Neonatal Critical Congenital Heart Disease

Feasibility study of screening for congenital heart disease in neonates by using pulse oximetry combined with clinical assessment

Use of Pulse Oximetry Pulsatility Index Screening for Critical Congenital Heart Disease

Progresses of Screening for Congenital Heart Defects in Neonates

Clinical Screening of Congenital Heart Disease in Neonates: a Literature Review on Five Studies